Relief Therapeutics Holding SA (ETR:RLF)

PRESS RELEASE

published on 10/29/2024 at 07:00, 1 year 8 months ago

Relief Therapeutics Announces Publication of Plain Language Summary on PKU GOLIKE
Relief Therapeutics announced the publication of a Plain Language Summary on PKU GOLIKE for phenylketonuria management, highlighting findings on prolonged-release protein substitute with similarities to natural proteins

Medical Research Relief Therapeutics PKU GOLIKE Phenylketonuria Plain Language Summary
BRIEF

published on 10/25/2024 at 07:05, 1 year 8 months ago

Relief Therapeutics Unveils Promising Study Results for RLF-OD032

Clinical Study Patent Filing RLF-OD032 Phenylketonuria Drug Absorption
BRIEF

published on 10/25/2024 at 07:05, 1 year 8 months ago

Relief Therapeutics dévoile les résultats prometteurs d'une étude sur RLF-OD032

Étude Clinique RLF-OD032 Dépôt De Brevet Phénylcétonurie Absorption Des Médicaments
PRESS RELEASE

published on 10/25/2024 at 07:00, 1 year 8 months ago

Relief Therapeutics Reports New Study Results for RLF-OD032 and Files Provisional Patents
Relief Therapeutics reports positive study results for RLF-OD032, showing superior absorption in fasted state compared to KUVAN®, enabling flexible dosing. New patents filed for innovative PKU treatment

Study Results Relief Therapeutics RLF-OD032 Phenylketonuria Provisional Patents
BRIEF

published on 10/21/2024 at 07:05, 1 year 8 months ago

Relief Therapeutics Secures European Patent for RLF-TD011

Orphan Drug Designation Relief Therapeutics RLF-TD011 European Patent Epidermolysis Bullosa
BRIEF

published on 10/21/2024 at 07:05, 1 year 8 months ago

Relief Therapeutics obtient un brevet européen pour RLF-TD011

Désignation De Médicament Orphelin THÉRAPEUTIQUE DE SECOURS RLF-TD011 Brevet Européen Epidermolyse Bulleuse
PRESS RELEASE

published on 10/21/2024 at 07:00, 1 year 8 months ago

Relief Therapeutics Receives Notice of Allowance for European Patent Covering RLF-TD011 for Epidermolysis Bullosa Wound Treatment
Relief Therapeutics receives Notice of Allowance for European Patent covering RLF-TD011 for Epidermolysis Bullosa wound treatment. The patent will protect RLF-TD011 until 2040 in key European countries, with applications under review in other major markets

Relief Therapeutics RLF-TD011 European Patent Epidermolysis Bullosa Wound Treatment
BRIEF

published on 10/08/2024 at 07:05, 1 year 9 months ago

Relief Therapeutics Reveals Promising Results in Clinical Trial for Epidermolysis Bullosa

Clinical Trial Relief Therapeutics RLF-TD011 Epidermolysis Bullosa Microbiome Diversity
BRIEF

published on 10/08/2024 at 07:05, 1 year 9 months ago

Relief Therapeutics révèle des résultats prometteurs dans un essai clinique sur l'épidermolyse bulleuse

Essai Clinique THÉRAPEUTIQUE DE SECOURS RLF-TD011 Epidermolyse Bulleuse Diversité Du Microbiome
PRESS RELEASE

published on 10/08/2024 at 07:00, 1 year 9 months ago

Relief Therapeutics Announces Promising Preliminary Results of RLF-TD011 Clinical Trial in Epidermolysis Bullosa
Relief Therapeutics reports promising preliminary results of RLF-TD011 clinical trial for epidermolysis bullosa, showing reduced Staphylococcus aureus and improved microbiome diversity

Microbiome Clinical Trial Relief Therapeutics RLF-TD011 Epidermolysis Bullosa

Published on 07/09/2026 at 10:00, 39 minutes ago

GMV Minerals Announces Completion of 16 Diamond Drill Holes on the Mexican Hat Gold Project in SE Arizona - Drill Assays Pending with ~1500 Samples Submitted to Date
Published on 07/09/2026 at 09:35, 1 hour 4 minutes ago

Haier Europe Appoints Stagwell (STGW) as Creative Agency for the Haier Brand, Following Ingenuity+ Pitch Process
Published on 07/09/2026 at 09:01, 1 hour 38 minutes ago

Apex Critical Metals Announces Listing of Common Shares on Euronext Access Paris
Published on 07/09/2026 at 08:00, 2 hours 39 minutes ago

Caledonia Mining Corporation Plc: Notification of Relevant Change to Significant Shareholder
Published on 07/09/2026 at 00:00, 10 hours 39 minutes ago

Alset AI Announces Closing of Shares for Debt Transaction

View all ACCESSWIRE

Published on 07/09/2026 at 10:00, 39 minutes ago

Axxam and HeartBeat.bio partner to advance human-relevant cardiovascular drug discovery and cardiac safety assessment
Published on 07/09/2026 at 10:00, 39 minutes ago

FUCHS SE announces changes to the Supervisory Board planned for 2027
Published on 07/09/2026 at 09:05, 1 hour 34 minutes ago

TeamViewer Named a Leader in IDC MarketScape: Worldwide Digital Employee Experience 2026 Vendor Assessment
Published on 07/09/2026 at 09:05, 1 hour 34 minutes ago

ehamarkets Launches ehamarkets AI, Bringing 24/7 Intelligent Trading Assistance to Global Traders
Published on 07/09/2026 at 09:00, 1 hour 39 minutes ago

Porsche delivers 122,306 sports cars in the first half of the year

View all EQS

Published on 07/09/2026 at 07:30, 3 hours 9 minutes ago

Half-year liquidity contract statement June 30, 2026
Published on 07/09/2026 at 07:30, 3 hours 9 minutes ago

Half-year liquidity contract statement June 30, 2026
Published on 07/09/2026 at 07:30, 3 hours 9 minutes ago

Bilan semestriel - 30 juin 2026
Published on 07/09/2026 at 07:30, 3 hours 9 minutes ago

Bilan semestriel - 30 juin 2026
Published on 07/08/2026 at 20:00, 14 hours 39 minutes ago

ALTAREA - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL

View all LES ECHOS COMFI WIRE

News